Reaksi Drug Safety News 2017 - Issue 6/2017

Print

User Rating: 1 / 5

Star ActiveStar InactiveStar InactiveStar InactiveStar Inactive
 

Reaksi Drug Safety News 2017,

Issue 6/2017

 

  • Ketamine: Risk of Severe Liver Damage with Repeated and/or Prolonged Use at High Doses
  • Recombinant Human Erythropoietins: Risk of Severe Cutaneous Adverse Reactions (SCARs)

 



 		  
  DOWNLOAD PDF

 

 

 


  Reaksi Archive